Delivery Order SPE2DR25D3501-SPE2DR26FL9VW
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count) valued at $11,571.36 under a firm fixed-price contract. The award was made on November 14, 2025, with an ultimate completion date of November 17, 2025. This non-competitive delivery order represents a routine pharmaceutical procurement to support federal medical supply needs, with performance to occur at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count packages) under a firm fixed-price arrangement. The contract, valued at $38,252.15, represents a single delivery order executed on December 2, 2025, with completion scheduled for December 3, 2025. This award was made on a competitive basis with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count units) with a ceiling value of $35,990.01. This competitively awarded, firm fixed-price delivery order has an ultimate completion date of September 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this procurement. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside delivery order carries a ceiling value of $6,130.99 under a firm fixed-price arrangement, with an ultimate completion date of November 17, 2025. The order will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count) with a contract ceiling value of $9,131.84. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation, reflecting the contractor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count) with a ceiling value of $1,151.04. This firm fixed-price delivery order, which was competitively awarded with no set-aside designation, represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The place of performance is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $7,553.06 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count) with an ultimate completion date of December 9, 2025. This is a firm fixed price delivery order with no set-aside designation, reflecting competitive award criteria. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Ondansetron ODT 4 mg tablets in a quantity of 30 units, with a contract ceiling value of $2,421.15. This is a firm fixed price delivery order with an ultimate completion date of December 12, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count units) with a ceiling value of $7,314.49 under a firm fixed-price contract. The award was issued on December 8, 2025, with an ultimate completion date of December 9, 2025, and represents a non-set-aside competitive procurement. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units, with a contract ceiling value of $11,310.31. This non-competed delivery order was awarded on December 4, 2025, with an ultimate completion date of December 5, 2025, under firm fixed pricing terms. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters...
- SPE2DR25D3501Indefinite Delivery Contract
- SPE2DR25D3501-SPE2DR26FL9VWDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) with a ceiling value of $26,055.15. This competitively awarded, firm fixed-price delivery order was issued on December 3, 2025, with an ultimate completion date of December 4, 2025. The contract is not designated as a set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. The IDC enables AmerisourceBergen to provide a broad range of pharmaceutical products, medical supplies, and specialty medications to support military healthcare programs globally. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen has demonstrated capability to fulfill diverse pharmaceutical requirements through open competition with the Defense Logistics Agency's Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $26.1k | 12/2/25 |